Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-17-072143
Filing Date
2017-12-06
Accepted
2017-12-06 20:51:25
Documents
2
Period of Report
2017-12-06

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 4561
2 EX-24.1 ex-24d1.htm EX-24.1 9170
  Complete submission text file 0001104659-17-072143.txt   15046
Mailing Address 113 HARTWELL AVE LEXINGTON MA 02421
Business Address 113 HARTWELL AVE LEXINGTON MA 02421 617-301-9400
Quanterix Corp (Issuer) CIK: 0001503274 (see all company filings)

EIN.: 208957988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments

Mailing Address C/O QUANTERIX CORPORATION 113 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Roskey Mark T. (Reporting) CIK: 0001724565 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38319 | Film No.: 171243354